United Therapeutics | UTHR - Assets

Stock Price
478.27
Daily Change
3.27 0.69%
Monthly
-2.33%
Yearly
35.32%
Q1 Forecast
455.03

United Therapeutics reported $7.35B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Amarin USD 659.81M 10.31M Sep/2025
Ardelyx USD 486.17M 19.4M Sep/2025
Baxter International USD 21.07B 21M Sep/2025
Bayer EUR 104.21B 1.03B Sep/2025
Biogen USD 29.21B 877.3M Sep/2025
BioMarin Pharmaceutical USD 7.61B 158.53M Sep/2025
Gilead Sciences USD 58.53B 2.81B Sep/2025
GlaxoSmithKline GBP 61.34B 2.08B Sep/2025
Halozyme Therapeutics USD 2.22B 167.33M Sep/2025
Insmed USD 2.36B 119.12M Sep/2025
Ionis Pharmaceuticals USD 3.03B 47.96M Sep/2025
J&J USD 192.82B 573M Sep/2025
Moderna USD 12.14B 125M Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
PTC Therapeutics USD 2.64B 9.54M Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Sarepta Therapeutics USD 3.49B 186.38M Sep/2025
Teva Pharmaceutical Industries USD 40.75B 892M Dec/2025
United Therapeutics USD 7.35B 556.9M Sep/2025
Vertex Pharmaceuticals USD 24.86B 825.6M Sep/2025